Several previous studies have reported the involvement of Rab3B in hepatocellular carcinoma, glioma, breast cancer, and prostate cancer (Tsunedomi et al. 2022; Liu et al. 2014; Ye et al. 2014; Tan et al. 2012). The gene discussed is RAB3B; the disease is hepatocellular carcinoma.